Andrew Freeman, MD
Radiation Oncology · Delaware, OHNPI 1386854875
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Varian Medical Systems, Inc. accounts for 61.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $1,235 and has fallen 91.6% since, to $104 in 2025.
Across 11 payments — averaging $183.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Varian Medical Systems, Inc.$1K
- GE HealthCare$550
- Siemens Medical Solutions USA, Inc.$104
- Progenics Pharmaceuticals, Inc.$101
- Bayer$18
- Pfizer$16
What the payments were for
- Consulting fees$55027%
- Travel & lodging$1,00750%
- Food & beverage$45122%
- Education$161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Varian Medical Systems, Inc. | 6 | $1,235 |
| GE HealthCare | 1 | $550 |
| Siemens Medical Solutions USA, Inc. | 1 | $104 |
| Progenics Pharmaceuticals, Inc. | 1 | $101 |
| Bayer | 1 | $18 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Halcyon$563
- Treatment Planning Systems$380
- Eclipse Treatment Planning System for External Beam Radiation Therapy$104
- PYLARIFY$101
How this compares
$2,023 in reported general payments places this provider in the 75th percentile of 255 radiation oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 34 | $503 |
| Dexamethasone | 19 | $199 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $196 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $102 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Delaware
- Steven KurtzmanGarfield Heights$833K
- Joshua PalmerColumbus$123K
- Norleena PoynterSandusky$90K
- Daniel SprattCleveland$86K
- Shlomo KoyfmanCleveland$72K
- Gerald SokolCleveland$61K
- Peter FriedFairfield$45K
- Rahul TendulkarCleveland$26K
- Sujith BaligaColumbus$26K
- Anthony ParavatiKettering$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.